Hydrocortisone Market Report 2026

Hydrocortisone Market Overview

• Hydrocortisone market size has reached to $1.62 billion in 2025 • Expected to grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Rising Prevalence Of Inflammatory And Autoimmune Diseases To Drive Growth In Hydrocortisone Market • Market Trend: Hydrocortisone And Butyrate Combination Therapies Expand Treatment Horizons • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hydrocortisone Market?

Hydrocortisone is a corticosteroid hormone naturally produced by the adrenal glands and vital for regulating metabolism and immune responses. It is synthesized and used to treat various conditions, primarily as an anti-inflammatory agent, often applied topically to alleviate skin inflammation and itching. The main types of hydrocortisone include cream, injections, and tablets. Cream hydrocortisone products are topical medications applied directly to the skin to reduce inflammation, itching, and irritation caused by various skin conditions such as eczema, dermatitis, and insect bites. The products are administered through different routes, such as parenteral, oral, and topical, for applications including adrenocortical dysfunction, adrenergic syndrome, high blood calcium, thyroiditis, rheumatoid arthritis, dermatitis, asthma, chronic obstructive pulmonary disease, and others. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Hydrocortisone Market Growth Forecast?

The hydrocortisone market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising incidence of autoimmune and respiratory diseases, growing self-medication through otc creams, development of improved delivery systems, expanding geriatric population, increased access through online pharmacies. Major trends in the forecast period include growing demand for topical corticosteroids in dermatology, increasing use of low-dose and otc hydrocortisone products, expansion of hydrocortisone use in chronic inflammatory disorders, rising adoption of extended-release oral formulations, focus on safer long-term corticosteroid therapies.

Global Hydrocortisone Market Segmentation

1) By Type: Cream, Injection, Tablet 2) By Route Of Administration: Parenteral, Oral, Topical 3) By Application: Adrenocortical Dysfunction, Rheumatoid Arthritis, Dermatitis, Asthma And Chronic Obstructive Pulmonary Disease, Other Applications 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Cream: Topical Hydrocortisone Cream (0.5%, 1%, 2.5%), Hydrocortisone Ointment 2) By Injection: Hydrocortisone Sodium Succinate Injection, Hydrocortisone Acetate Injection 3) By Tablet: Oral Hydrocortisone Tablets (5mg, 10mg, 20mg), Extended-Release Hydrocortisone Tablets

What Are The Drivers Of The Hydrocortisone Market?

The increasing prevalence of inflammatory and autoimmune diseases is expected to propel the growth of the hydrocortisone market going forward. Inflammatory and autoimmune diseases are conditions where the immune system mistakenly attacks the body's tissues, causing chronic inflammation and tissue damage. The rising adoption of treatments for inflammatory and autoimmune diseases is due to the increasing prevalence of these conditions and advancements in medical therapies. Hydrocortisone is used in inflammatory and autoimmune diseases such as severe asthma exacerbations to reduce airway inflammation and improve breathing rapidly. It is typically administered intravenously in emergencies. For instance, in August 2024, according to the data from Public Health Scotland, a Scotland-based national organization, reported that in 2023, the Scottish Multiple Sclerosis Register (SMSR) recorded 455 newly diagnosed MS patients. Therefore, the increasing prevalence of inflammatory and autoimmune diseases will drive the growth of the hydrocortisone industry. The rise in aging population is expected to drive the growth of the hydrocortisone market going forward. An aging population refers to a growing proportion of older individuals within a society due to increased life expectancy and declining birth rates. The aging population is increasing due to advancements in healthcare that have extended life expectancy. Hydrocortisone is used by the aging population to reduce inflammation and manage conditions such as arthritis, adrenal insufficiency, and skin disorders. For instance, in January 2024, according to the Population Reference Bureau, a US-based non-profit organization, reported that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. As a result, this age group’s proportion of the total U.S. population will grow from 17% to 23% during this period. Therefore, the rise in aging population is driving the growth of the hydrocortisone industry.

Key Players In The Global Hydrocortisone Market

Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Bayer AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Macleods Pharmaceuticals Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Taro Pharmaceutical Industries Ltd., Lannett Company Inc., Almirall SA, Leo Pharma AS, Perrigo Company plc, Recordati S.p.A.

Global Hydrocortisone Market Trends and Insights

Major companies operating in the hydrocortisone market are focusing on combination therapies, such as lotions combined with butyrate active ingredients, to enhance treatment efficacy and broaden their product portfolios. Hydrocortisone combined with butyrate lotion offers a potential synergy in managing skin conditions by leveraging hydrocortisone's anti-inflammatory properties alongside butyrate's immunomodulatory effects and potential for improving skin barrier function. For instance, in November 2023, J. Molner AS., an Estonian-based pharmaceutical company, launched Hydrocortisone Butyrate Lotion, 0.1%, in the United States, marking a key milestone in its strategy to build a commercial platform for its pharmaceutical products in global markets. The newly available lotion is designed to treat inflammatory skin conditions, reflecting Molner's commitment to expanding its international market presence.

Regional Outlook

North America was the largest region in the hydrocortisone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hydrocortisone Market?

The hydrocortisone market consists of sales of hydrocortisone creams, ointments, lotions, and oral formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hydrocortisone Market Report 2026?

The hydrocortisone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocortisone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.